AI Can Unlock $4.5 Trillion in U.S. Labor Productivity Today, Reveals Cognizant's Latest "New Work, New World 2026" Report
Cognizant's study shows AI is accelerating faster than projected, with 93% of jobs potentially affected today Findings also point to the limits of AI's impact, with skilling and human judgment playing a critical role in how organizations capture...
IBM Introduces New Software to Address Growing Digital Sovereignty Imperative
Purpose-built to enable organizations to deploy their own secured, compliant and automated environments for AI-ready sovereign workloads ARMONK, N.Y., Jan. 15, 2026 /PRNewswire/ -- IBM (NYSE: IBM) today announced IBM Sovereign Core, the industry's...
Visa Supports Chinese Cardholders to Add Cards to Apple Pay for a More Convenient and Secure Payment Experience
SINGAPORE, Jan. 15, 2026 /PRNewswire/ -- Today, Visa, a world leader in digital payments, announced its support for Chinese Visa cardholders to pay with Apple Pay. Together with Apple, Visa will enable Chinese cardholders to add Visa cards[1] from...
Docquity Launches Engage™, an AI and Insights-Powered HCP Intelligence Engine for the Life Sciences Industry
SINGAPORE, Jan. 15, 2026 /PRNewswire/ -- Docquity, a leading health tech company in Asia, today announced the launch of Docquity Engage™, an AI and Insights-powered market intelligence engine designed to help life sciences companies better...
Belief BioMed Congratulates Partner AskBio on IND Acceptance by FDA for Investigational Gene Therapy for Late-Onset Pompe Disease
SHANGHAI, Jan. 15, 2026 /PRNewswire/ -- AskBio Inc. (AskBio), a gene therapy company wholly owned and independently operated as a subsidiary of Bayer AG, recently announced that the United States Food and Drug Administration (FDA) has accepted its...
CLO Secures Final Victory in Software Copyright Infringement Case Against Style3D; Court Recognizes Large-Scale Commercial Piracy
SHANGHAI, Jan. 15, 2026 /PRNewswire/ -- CLO Virtual Fashion ("CLO"), a leading provider of 3D fashion technology and end-to-end digital solutions, today announced that it has obtained a final and binding judgment from the Zhejiang Provincial High...
Hyundai Bioscience Confirms Entry into U.S. FDA Phase 2 Trials for Broad-Spectrum Antiviral 'XAFTY' Following 2026 Biotech Showcase Consensus
- UCSD's Dr. Davey Smith, former ACTIV-2 Protocol Chair, endorses 'Xafty' as "The weapon to end the virus war." - Announces "One Drug, Two Tracks" strategy: Targeting Dengue in Vietnam and Respiratory Viruses (Flu, COVID, RSV) in the U.S. with the...
JIOS Aerogel® Secures Hyundai Contract Through New Licensing Model
SINGAPORE, Jan. 15, 2026 /PRNewswire/ -- JIOS Aerogel (JIOS), a global leader in silica aerogel technology, today announced that its Korean manufacturing licensee has secured a major contract to supply Thermal Blade® thermal runaway barriers for...
iFAST Partners BlackRock and JPMorgan to Drive Discretionary Portfolio Adoption Among Wealth Advisers
SINGAPORE, Jan. 15, 2026 /PRNewswire/ -- iFAST Financial Singapore ("iFAST"), a wholly-owned subsidiary of iFAST Corporation Ltd, announced an expansion to its Discretionary Portfolio Management Solutions (DPMS) lineup with the launch of new...
AIM's Iterative Process High-Efficiency Diploid Rabies Vaccine Completes Phase III Clinical Trials, Efficacy Significantly Higher than Existing Market Products
HONG KONG, Jan. 15, 2026 /PRNewswire/ -- AIM Vaccine (06660.HK), a leading domestic vaccine company, announced on January 15 that its research and development of the iterative process high-efficiency diploid rabies vaccine has successfully completed...